bcma-targeting car-t: lessons moving forward
Published 5 years ago • 51 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
1:53
the detection and management of mnts following bcma-directed car-t therapy
-
0:53
incorporating bcma-targeted car-t therapy in the frontline treatment of multiple myeloma
-
1:27
bcma-targeted car-t therapy is tolerable in multiple myeloma with cns involvement
-
1:05
sequential therapy with teclistamab after failure of bcma-directed car-t & the value of bispecifics
-
1:13
car t-cells: targeting bcma
-
3:43
the future of car-t therapy
-
0:54
accessibility of car-t and the move from specialist centers
-
2:44
sequential cd19 and bcma car-t
-
41:39
2022 wmif | the cell therapy landscape | car-t to stem cells
-
2:32
a machine learning model to predict immunotherapy response in cancer patients
-
21:25
barcode medication administration system
-
1:23
moving car-t therapy to the outpatient setting
-
3:49
strategies to improve cost & access to car-t therapy
-
3:47
update on the guidelines for the diagnosis, grading & management of icaht following car-t therapy
-
4:51
promising bcma-targeting car-t cells for relapsed myeloma
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
1:31
integrating bcma-directed bispecifics and car-t into the myeloma treatment landscape
-
5:57
feasibility of bcma-directed car-t therapy in r/r al amyloidosis
-
1:29
sequencing bcma-targeted therapies in myeloma
-
1:59
investigating the mechanisms of initial & acquired resistance to bcma car-t therapy in myeloma
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
-
0:58
novel car-t constructs emerging in multiple myeloma for patients who experience loss of bcma